Literature DB >> 18426742

LDL species heterogeneity in the atherogenic dyslipidemia of polycystic ovary syndrome.

Suhail A R Doi1, Jasem M K Abbas, Lynne Parkinson, Jagadish Chakraborty, Abayomi O Akanji.   

Abstract

One of the important risk factors for coronary heart disease is dyslipidemia. Several lipid abnormalities have been studied in patients with polycystic ovary syndrome (PCOS), but the relationship between PCOS and low-density lipoprotein (LDL) subclass pattern is not clear. A case-control study was designed to look into lipid differences, and LDL size was analyzed by a newly developed polyacrylamide tube gel electrophoresis method. Results indicated that only PCOS status and serum triglyceride levels were independently associated with LDL particle size. The apolipoprotein (Apo)A-I level was higher in PCOS patients with small dense LDL (sdLDL). PCOS seems to result in smaller LDL particle size and higher ApoA-I levels independent of triglyceride levels. After adjusting for triglyceride levels, other traits of insulin resistance syndrome (IRS) were not associated with LDL size phenotype, suggesting that the IRS-related sdLDL is linked most strongly to alterations in triglyceride levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18426742     DOI: 10.1309/E7EGTTVCRFVBA7EC

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  5 in total

1.  Lipoprotein Particles in Adolescents and Young Women With PCOS Provide Insights Into Their Cardiovascular Risk.

Authors:  E Gourgari; M Lodish; R Shamburek; M Keil; R Wesley; M Walter; M Sampson; S Bernstein; D Khurana; C Lyssikatos; S Ten; A Dobs; A T Remaley; C A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2015-09-15       Impact factor: 5.958

Review 2.  Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL.

Authors:  Jelena Vekic; Aleksandra Zeljkovic; Arrigo F G Cicero; Andrej Janez; Anca Pantea Stoian; Alper Sonmez; Manfredi Rizzo
Journal:  Medicina (Kaunas)       Date:  2022-02-16       Impact factor: 2.430

3.  Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.

Authors:  Andrea Roe; Jennifer Hillman; Samantha Butts; Mathew Smith; Daniel Rader; Martin Playford; Nehal N Mehta; Anuja Dokras
Journal:  J Clin Endocrinol Metab       Date:  2014-02-10       Impact factor: 5.958

4.  'Triglyceride effect' on the dynamics of plasma lipoproteins and its possible link to atherogenesis.

Authors:  Dhastagir Sultan Sheriff; Elshaari Faraj Ali; Manopriya T Priya
Journal:  Libyan J Med       Date:  2012-08-03       Impact factor: 1.657

Review 5.  Dyslipidemia in women with polycystic ovary syndrome.

Authors:  Jin Ju Kim; Young Min Choi
Journal:  Obstet Gynecol Sci       Date:  2013-05-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.